On the contrary, the approval and adoption of antigen tests in western countries is relatively slow In Asia Pacific, the market captured maximum revenue share in 2020 with India as one of the key users of antigen tests The home care segment is projected to grow at a lucrative pace during the forecast period owing to the increased approval of over-the-counter tests with no prescription required The clinics and hospitals segment dominated the market in 2020 with the highest test penetration in terms of usage in this end-use segment The reagents and kits segment is anticipated to register the fastest CAGR over the forecast period due to the rising popularity of self-administered test kits The services segment dominated the market and accounted for the largest revenue share in 2020 owing to the increasing usage of Rapid Antigen Tests (RATs) by service providers including labs, hospitals, and others
While this test mode is currently unavailable for large-scale use, both private and public organizations across the globe are working on prototypes, with over 50 currently in development.ĬOVID-19 Antigen Test Market Report Highlights With the expected decline in COVID-19 cases, PoC tests can become critical in the determination of infected individuals and asymptomatic carriers to assure their isolation from the general population. This mode of testing can deliver results in real-time, and thus, help accelerate patient admission and treatment processes, leading to improved patient outcomes. Moreover, integration of antigen detection in disease screening enables its use for PoC, community-wide, or door-to-door testing. With the rising number of new infection cases coupled with the increasing popularity of antigen testing, a substantial number of companies are making significant attempts to boost their market presence in this arena, thereby driving the market.Īntigen-based screening for acute phase diagnosis is gaining momentum, as antigens are more evident in the sputum from the onset of symptoms. The global COVID-19 antigen test market size is expected to reach USD 8.3 billion by 2027, expanding at a CAGR of 6.7% from 2021 to 2027.Ī COVID-19 antigen test can help fill the gap in the testing landscape by enabling fast diagnoses in clinical settings.
0 kommentar(er)
